metsera glp-1 Reports Highly Competitive Results from Ongoing Trial of Novel, Potential Once-Monthly Injectable Receptor Agonist MET-097 Is This the First Real
Description
You may cancel your plan anytime
However, due to its indicated short half-live, GLP-1 peptide is an unattractive therapeutic agent on itself, which stimulated the quest for GLP-1 based compounds with better bioavailability
Timestamps (00:01:26) What are GLP-1 Drugs (00:05:22) How GLP-1 drugs reduce inflammation (00:06:24) Potential Side Effects and Risks (00:09:00) Nutrition and Muscle Maintenance on GLP-1 (00:18:52) How GLP-1 drugs affect the gut-brain axis (00:22:01) Future Implications in Medicine (00:25:37) Natural Ways to Boost GLP-1 Enjoying the show
Our findings align with a growing body of evidence
2023;131:e37e39
Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials
